Your browser doesn't support javascript.
loading
Effect of ketogenic diet for drug-resistant epilepsy on immunological cells.
Nassar, May Fouad; El-Gendy, Yasmin Gamal Abdou; Hamza, Mohamed Tarif; Mohamed, Marwa Nasser; Radwan, Nesrine.
Afiliación
  • Nassar MF; Pediatric Clinical Nutrition Unit, Children's Hospital, Ain Shams University, Cairo, Egypt. maie_nassar@yahoo.co.uk.
  • El-Gendy YGA; Pediatric Clinical Nutrition Unit, Children's Hospital, Ain Shams University, Cairo, Egypt.
  • Hamza MT; Clinical Pathology Department, Ain Shams University, Cairo, Egypt.
  • Mohamed MN; Ministry of Health Hospitals, Cairo, Egypt.
  • Radwan N; Pediatric Allergy, Immunology and Rheumatology Unit, Children's Hospital, Ain Shams University, Cairo, Egypt.
Neurol Sci ; 43(3): 1987-1992, 2022 Mar.
Article en En | MEDLINE | ID: mdl-34449000
ABSTRACT
BACKGROUND AND AIM OF THE WORK Ketogenic diet (KD) is one of the treatments in drug-resistant epilepsy (DRE). The current study aimed at assessing the effect of KD-induced ketosis on different immunological cells since ketosis is reported to affect neutrophil function.

METHODOLOGY:

We recruited 21 pediatric patients diagnosed with DRE assigned to start KD. Anthropometric measurements, complete blood picture with differential count, phagocytic function, lymphocyte subsets, and IgG estimation were estimated initially and after 6 months of KD.

RESULTS:

There were no differences between the initial total leucocytic, neutrophil, and lymphocytic counts as well as the lymphocyte subsets, and the values after 6 months of KD. IgG values showed significant increase yet the values were still within the reference ranges. For the innate immune system, the phagocytic index was assessed and it showed a marked statistical reduction in patients after KD.

CONCLUSION:

KD has no effect on neutrophil and lymphocytic counts as well as the number of adaptive and immune cells; nevertheless, it causes a reduction in phagocytic index in DRE. Accordingly, further detailed study for the full immunological profile and function is needed to ensure the safety of this therapeutic line and correlate it with the clinical history.
Asunto(s)
Palabras clave

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Preparaciones Farmacéuticas / Dieta Cetogénica / Epilepsia Refractaria Tipo de estudio: Diagnostic_studies Idioma: En Revista: Neurol Sci Asunto de la revista: NEUROLOGIA Año: 2022 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Preparaciones Farmacéuticas / Dieta Cetogénica / Epilepsia Refractaria Tipo de estudio: Diagnostic_studies Idioma: En Revista: Neurol Sci Asunto de la revista: NEUROLOGIA Año: 2022 Tipo del documento: Article